Minimal targetcoverage was 95% of the prescribed dose for all targets with at least 99% of the prescribed dose delivered to gross tumor and involved cervical lymph nodes.
Dosimetric specifications required that 95% of the PTV receive 100% of the prescribed dose and 100% of the PTV receive at least 95% of the prescribed dose.
Table 1 shows the DVCs that were determined by referencing the ultra high prescribed dose (86.4 Gy) IMRT case for PTV [30, 31] and the normal prescribed dose (74-78 Gy) IMRT case for OARs [32, 33].
Most veterans got far less than the prescribed dose while others received too much.
The patient received nearly six times her prescribed dose.
Tests by federal investigators on drugs that Dr. Hunter ordered from Mr. Courtney found that no sample contained more than 39percentt of the prescribed dose.
The median prescribed dose was 25.5 ml/kg/hr.
The planned dose inhomogeneity at the junction level resulted within ±10% of the prescribed dose.
Median dose reduction to organs at risk ranged from 30 80% of the prescribed dose.
These estimated absorbed doses are actual values for comparison with the prescribed dose values at each depth of patient tissue.
It was also not possible to study the prescribed dose.
